1. Home
  2. KTCC vs KYNB Comparison

KTCC vs KYNB Comparison

Compare KTCC & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

HOLD

Current Price

$3.03

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$7.88

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KTCC
KYNB
Founded
1969
1993
Country
US
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
31.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
KTCC
KYNB
Price
$3.03
$7.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.9K
28.4K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,871,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$2.21
$7.11
52 Week High
$3.69
$9.58

Technical Indicators

Market Signals
Indicator
KTCC
KYNB
Relative Strength Index (RSI) 56.24 44.69
Support Level $2.97 $7.11
Resistance Level $3.25 $8.25
Average True Range (ATR) 0.17 0.67
MACD 0.00 -0.03
Stochastic Oscillator 56.87 39.64

Price Performance

Historical Comparison
KTCC
KYNB

About KTCC Key Tronic Corporation

Key Tronic Corporation provides electronic manufacturing services, including engineering, materials management, manufacturing and assembly, in-house testing, and distribution to various countries. The company serves diverse industries such as pest control, personal protection, air purification, automotive, medical technology, and utilities inspection equipment. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly. Key Tronic operates manufacturing facilities in the United States, Vietnam, and Mexico, recently expanding with a new facility in Arkansas. Revenue is generated mainly through contract manufacturing and service agreement.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: